AstraZeneca to Develop Stem Cell Treatments

It was announced on September 13, that AstraZeneca has become the second major pharmaceutical company, after Pfizer, to collaborate with the University College of London to develop stem cells, in this case, to treat diabetic retinopathy. (Pfizer’s work with UCL is for AMD.) To read all about the new collaboration, please see my update. (Link)